Breaking News Instant updates and real-time market news.

OLN

Olin

$18.31

-0.04 (-0.22%)

08:30
11/04/19
11/04
08:30
11/04/19
08:30

Olin downgraded to Hold from Buy at Tudor Pickering

Tudor Pickering analyst Matthew Blair downgraded Olin to Hold from Buy with a $19 price target.

  • 12

    Nov

OLN Olin
$18.31

-0.04 (-0.22%)

10/17/19
JPMS
10/17/19
DOWNGRADE
Target $18
JPMS
Neutral
Olin downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Olin to Neutral from Overweight with a $18 price target.
10/17/19
JPMS
10/17/19
DOWNGRADE
Target $19
JPMS
Neutral
JPMorgan downgrades Olin to Neutral on caustic soda concerns
JPMorgan analyst Jeffrey Zekauskas downgraded Olin (OLN) to Neutral from Overweight with an unchanged price target of $19. When the recession comes, it will be "less friendly" to caustic soda pricing and profitability than past downturns, Zekauskas tells investors in a research note. Further, in the current economic environment, a sharp housing contraction is unlikely relative to industrial demand, as is the possibility of a sharp counter-cyclical rise in caustic soda prices stemming from a supply/demand squeeze, adds the analyst. The risk/reward characteristics of Olin and Westlake Chemical (WLK) are then less favorable, he says. Zekauskas downgrades Olin to Neutral, matching his rating on Westlake.
11/04/19
RHCO
11/04/19
DOWNGRADE
Target $19
RHCO
Hold
Olin downgraded to Hold from Buy at SunTrust
SunTrust analyst James Sheehan downgraded Olin to Hold from Buy with a $19 price target.
11/04/19
RHCO
11/04/19
DOWNGRADE
Target $19
RHCO
Hold
Olin downgraded to Hold from Buy at SunTrust
SunTrust analyst James Sheehan downgraded Olin to Hold from Buy with a price target of $19, down from $27, after its Q3 earnings miss and a cut in its FY19 guidance. The analyst says his expected strengthening in supply/demand for chlor-alkali did not materialize since "chlorine demand has outpaced caustic soda demand", which is the reverse of the typical trend during economic slowdown. Sheehan adds that the high chlor-alkali operating rates are likely to be sustainable next year, which should prevent caustic soda prices from gaining traction. The analyst further notes that at current levels, he sees the upside and downside risks on the stock as "fairly balanced".

TODAY'S FREE FLY STORIES

10:25
12/09/19
12/09
10:25
12/09/19
10:25
General news
Concerns over a year-end spike in the money markets »

Concerns over a year-end…

10:25
12/09/19
12/09
10:25
12/09/19
10:25
Conference/Events
JPMorgan Mexican strategist to hold an analyst/industry conference call »

Mexican Equity Strategist…

10:25
12/09/19
12/09
10:25
12/09/19
10:25
Conference/Events
UBS alternative energy windham to hold an analyst/industry conference call »

Alternative Energy &…

ZG

Zillow

$40.54

-0.18 (-0.44%)

, SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ZG

Zillow

$40.54

-0.18 (-0.44%)

SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

PAA

Plains All American

$17.29

-0.01 (-0.06%)

PAGP

Plains GP Holdings

$17.37

0.01 (0.06%)

SSKN

Strata Skin Sciences

$2.20

0.04 (1.85%)

ZYME

Zymeworks

$41.25

-0.45 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 30

    Dec

  • 04

    Feb

MMM

3M

$169.82

-1.675 (-0.98%)

, PNC

PNC Financial

$153.68

-0.13 (-0.08%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MMM

3M

$169.82

-1.675 (-0.98%)

PNC

PNC Financial

$153.68

-0.13 (-0.08%)

M

Macy's

$14.96

-0.19 (-1.25%)

CVX

Chevron

$117.18

-0.8 (-0.68%)

HBIO

Harvard Bioscience

$2.83

-0.12 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 15

    Jan

QRVO

Qorvo

$109.72

3.04 (2.85%)

, SWKS

Skyworks

$104.55

3.15 (3.11%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

QRVO

Qorvo

$109.72

3.04 (2.85%)

SWKS

Skyworks

$104.55

3.15 (3.11%)

FATE

Fate Therapeutics

$19.69

6.05 (44.35%)

WING

Wingstop

$84.26

4.04 (5.04%)

HUN

Huntsman

$23.31

0.48 (2.10%)

FTV

Fortive

$74.68

1.82 (2.50%)

DOW

Dow Inc.

$53.29

0.04 (0.08%)

KRA

Kraton

$23.96

0.92 (3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

TPR

Tapestry

$25.85

0.305 (1.19%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Options
Upside February calls see heavy trading in Tapestry »

Upside February calls see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

, GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

10:19
12/09/19
12/09
10:19
12/09/19
10:19
Hot Stocks
SpringsWorks reports Glaxo presentation of preclinical data on nirogacestat »

SpringWorks Therapeutics…

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/09/19
12/09
10:17
12/09/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$44.49

3.56 (8.70%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Hot Stocks
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$22.25

7.85 (54.51%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Forty Seven announces preclinical proof-of-concept data for FSI-174 »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

NKTR

Nektar

$22.00

1.55 (7.58%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Nektar announces presentation of data for NKTR-255 at ASH »

Nektar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UPS

UPS

$116.87

-0.67 (-0.57%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
UPS reports expansion of UPS Worldwide Express, Express Plus across 40 countries »

UPS announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$60.30

-0.69 (-1.13%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Options
Centene put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Breaking Hot Stocks news story on Constellation Pharmaceuticals »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

ACHN

Achillion

$6.19

0.02 (0.32%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Achillion reports 'positive' data from Phase 2 danicopan, eculizumab study »

Achillion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ATRA

Atara Biotherapeutics

$14.24

0.25 (1.79%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Hot Stocks
Atara reports updated long-term clinical results from Tab-cel EBV+ PTLD study »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$102.78

-0.525 (-0.51%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Conference/Events
Globant management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 16

    Jan

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:12
12/09/19
12/09
10:12
12/09/19
10:12
Hot Stocks
Constellation Pharmaceuticals provides update on MANIFEST clinical trial »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

DTIL

Precision BioSciences

$18.00

-1.66 (-8.44%)

10:11
12/09/19
12/09
10:11
12/09/19
10:11
Hot Stocks
Breaking Hot Stocks news story on Precision BioSciences »

Precision BioSciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

MTEM

Molecular Templates

$12.23

(0.00%)

10:10
12/09/19
12/09
10:10
12/09/19
10:10
Hot Stocks
Molecular Templates announces presentations of two posters at ASH »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.72

0.545 (1.75%)

10:10
12/09/19
12/09
10:10
12/09/19
10:10
Conference/Events
Avis Budget management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

XNCR

Xencor

$41.27

0.25 (0.61%)

10:08
12/09/19
12/09
10:08
12/09/19
10:08
Hot Stocks
Xencor presents Initial Data from Phase 1 Study of XmAb 13676 »

Xencor announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

SGEN

Seattle Genetics

$117.12

-0.4 (-0.34%)

, TAK

Takeda Pharmaceutical

$20.12

-0.15 (-0.74%)

10:08
12/09/19
12/09
10:08
12/09/19
10:08
Hot Stocks
Seattle Genetics, Takeda announce additional analyses of Adcetris »

Seattle Genetics (SGEN)…

SGEN

Seattle Genetics

$117.12

-0.4 (-0.34%)

TAK

Takeda Pharmaceutical

$20.12

-0.15 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.